Thermo Scientific, UT Arlington receive U.S. patent for Dionex QD detector

The University of Texas at Arlington and Thermo Fisher Scientific Inc., the world leader in serving science, announced that they have been granted a United States patent (#8,293,099) for a novel charge detector for ion chromatography that they developed together. The invention has been commercialized as the Thermo Scientific Dionex QD detector, which was introduced in March 2012 at the Pittcon Conference and Expo.

The detector, used in combination with the Thermo Scientific Dionex ICS-4000 ion chromatography system, is well suited for analysis of polyphosphates by environmental testing laboratories, organic acids in the food and beverage industry and amines in chemicals. It offers an easy-to-use alternative to traditional conductivity detectors for peak identification, peak purity analysis and quantification, while generally providing more information.

The charge detector was invented by UT Arlington chemistry professor Purnendu "Sandy" Dasgupta, along with Bingcheng Yang of his research group and Kannan Srinivasan, technical director for Dionex Corporation, a subsidiary of Thermo Fisher Scientific. The patent is jointly owned by Dionex and the UT System.

Dasgupta has received numerous national and international awards for his work in ion chromatography, including the prestigious 2012 Dal Nogare Award, given by the Chromatography Forum of the Delaware Valley, and the 2011 American Chemical Society Award in Chromatography. Dasgupta has been awarded more than $18 million in research grants and is the author of more than 400 scientific papers. The latest patent is his 23rd in the United States.

"We are particularly proud that this innovation has made its way into the marketplace," said Carolyn Cason, vice president for research at UT Arlington. "One of the hallmarks of a vibrant research university is the ability to team with industry to advance scientific application, and this is what Dr. Dasgupta has done."

"We see this as a game changer," said Chris Pohl, Thermo Fisher vice president, chromatography chemistry. "Charge detection, when combined with suppressed conductivity detection, can be used as a confirmatory tool or as a complementary detector to provide additional analytical information."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2019, June 20). Thermo Scientific, UT Arlington receive U.S. patent for Dionex QD detector. News-Medical. Retrieved on October 07, 2024 from https://www.news-medical.net/news/20121220/Thermo-Scientific-UT-Arlington-receive-US-patent-for-Dionex-QD-detector.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Thermo Scientific, UT Arlington receive U.S. patent for Dionex QD detector". News-Medical. 07 October 2024. <https://www.news-medical.net/news/20121220/Thermo-Scientific-UT-Arlington-receive-US-patent-for-Dionex-QD-detector.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Thermo Scientific, UT Arlington receive U.S. patent for Dionex QD detector". News-Medical. https://www.news-medical.net/news/20121220/Thermo-Scientific-UT-Arlington-receive-US-patent-for-Dionex-QD-detector.aspx. (accessed October 07, 2024).

  • Harvard

    Thermo Fisher Scientific Inc.. 2019. Thermo Scientific, UT Arlington receive U.S. patent for Dionex QD detector. News-Medical, viewed 07 October 2024, https://www.news-medical.net/news/20121220/Thermo-Scientific-UT-Arlington-receive-US-patent-for-Dionex-QD-detector.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Thermo Fisher Scientific and Symphogen extend collaboration to boost drug discovery and development